2000 patients monitored: how safe is this sedative for routine scopes?
NCT ID NCT05254366
First seen Jan 06, 2026 · Last updated Jun 12, 2026 · Updated 22 times
Summary
This study looked at the safety of a sedative called remazolam in 2000 Chinese patients undergoing painless stomach or colon exams. Researchers tracked side effects and serious reactions to understand how the drug performs in everyday medical practice. The goal was to gather real-world safety information, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROSCOPIC AND COLONOSCOPIC SEDATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430021, China
Conditions
Explore the condition pages connected to this study.